Home/Filings/4/0000905148-20-000773
4//SEC Filing

venBio Global Strategic Fund II L.P. 4

Accession 0000905148-20-000773

CIK 0001744659other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 7:00 PM ET

Size

15.6 KB

Accession

0000905148-20-000773

Insider Transaction Report

Form 4
Period: 2020-07-01
Transactions
  • Sale

    Common Stock

    2020-07-01$34.45/sh108,064$3,723,0103,041,955 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-02$33.63/sh3,800$127,8053,038,155 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-06$33.83/sh4,603$155,7213,033,552 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2020-07-01$34.45/sh108,064$3,723,0103,041,955 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-02$33.63/sh3,800$127,8053,038,155 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-06$33.83/sh4,603$155,7213,033,552 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2020-07-02$33.63/sh3,800$127,8053,038,155 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-06$33.83/sh4,603$155,7213,033,552 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-01$34.45/sh108,064$3,723,0103,041,955 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2020-07-02$33.63/sh3,800$127,8053,038,155 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-01$34.45/sh108,064$3,723,0103,041,955 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-06$33.83/sh4,603$155,7213,033,552 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2020-07-02$33.63/sh3,800$127,8053,038,155 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-06$33.83/sh4,603$155,7213,033,552 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-07-01$34.45/sh108,064$3,723,0103,041,955 total(indirect: See footnote)
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $35.20, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $33.79, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $34.07, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  • [F4]These shares are held by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. Robert Adelman and Corey Goodman are directors of venBio Global Strategic GP II, Ltd. Each of venBio Global Strategic GP II, L.P., venBio Global Strategic GP II, Ltd., Mr. Adelman and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein.

Documents

1 file

Issuer

Akero Therapeutics, Inc.

CIK 0001744659

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001634632

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 7:00 PM ET
Size
15.6 KB